| Progression‐free survival ‐ narrative data | ||||
|---|---|---|---|---|
| Study | Time point | Amifostine | Control | Comments |
| Haddad 2009 | Median follow‐up 34 months after radiotherapy, minimum 26 months | "No differences noted" | ||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.